Back to Portfolio
Status
Current
Tamarind Health Limited (“Tamarind Health”) is a premier oncology and cardiology group in Asia, encompassing OncoCare Medical, one of the largest private oncology practices in Singapore, providing comprehensive consulting, diagnosis, and treatment services across various subspecialties; TalkMed, a leading private provider of medical oncology and palliative care in Singapore operating under the brand name Parkway Cancer Centre; Singapore Breast Surgery Centre, an integrated breast cancer care group, operating under the brands Solis and Luma, covering the entire breast cancer theragnostic process, including screening, diagnostic imaging, pathology and surgery services; OncoCare Malaysia, a leading private oncology practice in Kuala Lumpur; OncoCare Hong Kong, a premium oncology cancer centre group in Hong Kong, providing a full suite of oncology services across various cancer types, including medical oncology, radiation oncology, wholesale pharmacy, and colorectal surgical services; Central Luzon Integrated Oncology Centre, an oncology practice in Mother Teresa of Calcutta Medical Center in San Fernando, Philippines, providing tomotherapy and chemotherapy services; Can-Care, a retailer and distributor of post-cancer care products; and Novena Heart Centre, one of the leading multi-disciplinary cardiology group practices in Singapore, specializing in coronary intervention, heart rhythm management, heart failure, cardiac imaging, and cardiothoracic surgery.
Who we partnered with
65 Equity Partners partnered with founding doctors on the establishment of the Tamarind Health group. Through close collaboration with the doctors and management team, 65 Equity Partners is dedicated to maintaining Tamarind Health’s high standards of quality patient care and supporting its regional expansion plans.
What attracted us to the business
Tamarind Health has quality business fundamentals stemming from its market leading practices and specialists. It is well-positioned to capitalize on the regional secular tailwinds of an aging population, the rise in private healthcare spending, and Singapore’s status as a leading medical hub. We are excited about the opportunity to work with our partners to grow the group into a leading regional healthcare platform headquartered in Singapore.
Our value creation strategy
65 Equity Partners leveraged our connections in the Singapore and Southeast Asia healthcare sector as well as our international market access to support both organic and inorganic growth initiatives, to enhance operations, and to build a leading specialty pan-Asian healthcare platform delivering best-in-class healthcare services to an even broader patient base in the region.
Website – https://tamarindhealth.com/